Literature DB >> 12739043

Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis.

Reyhan Celiker1, Serpil Bal, Aysin Bakkaloğlu, Eda Ozaydin, Turgay Coskun, Alp Cetin, Fitnat Dinçer.   

Abstract

OBJECTIVE: The aims of this study were to evaluate bone mineral density (BMD) in patients with juvenile chronic arthritis (JCA), compare them with healthy controls, and assess the effects of disease activity and corticosteroid treatment on BMD.
METHODS: Twenty-eight patients diagnosed with JCA and 45 healthy controls were included in this study. Disease activity was determined by clinical and laboratory evaluation, Articular Disease Severity Score (ADSS), and the Juvenile Arthritis Functional Assessment Report (JAFAR). Bone mineral density of the lumbar spine was measured by dual energy X-ray absorptiometry (DEXA).
RESULTS: Patients with JCA showed significant decreases in BMD compared with healthy controls. The JCA patients treated with corticosteroids showed significantly lower BMDs than the healthy control group. Age of the patients and age of onset were found to correlate with BMD.
CONCLUSION: Our study showed that glucocorticoids were involved in the development of osteoporosis in JCA, with many other factors affecting bone mineralization. We could not demonstrate any relationship between BMD and disease activity, but the study data suggest that early onset disease is also an important factor in the development of osteoporosis in JCA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739043     DOI: 10.1007/s00296-002-0265-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

Review 1.  Consensus development conference: prophylaxis and treatment of osteoporosis.

Authors: 
Journal:  Osteoporos Int       Date:  1991-02       Impact factor: 4.507

2.  Bone mineral density and turnover in children with systemic juvenile chronic arthritis.

Authors:  R Brik; Z Keidar; D Schapira; O Israel
Journal:  J Rheumatol       Date:  1998-05       Impact factor: 4.666

3.  Bone mineral metabolism in juvenile chronic arthritis: the influence of steroids.

Authors:  M Bardare; M L Bianchi; M Furia; G G Gandolini; E Cohen; A Montesano
Journal:  Clin Exp Rheumatol       Date:  1991 Jan-Feb       Impact factor: 4.473

4.  Exercise response in children with and without juvenile rheumatoid arthritis: a case-comparison study.

Authors:  M J Giannini; E J Protas
Journal:  Phys Ther       Date:  1992-05

Review 5.  Bone mineral status in juvenile rheumatoid arthritis.

Authors:  C E Rabinovich
Journal:  J Rheumatol Suppl       Date:  2000-04

6.  Bone metabolism in juvenile rheumatoid arthritis.

Authors:  M L Bianchi; M Bardare; M P Caraceni; E Cohen; S Falvella; M Borzani; M G DeGaspari
Journal:  Bone Miner       Date:  1990-05

7.  Estimation of bone mineral density in children with juvenile rheumatoid arthritis.

Authors:  R Hopp; J Degan; J C Gallagher; J T Cassidy
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

8.  Osteoporosis in rheumatoid arthritis: effect of disease activity.

Authors:  R Celiker; Y Gökçe-Kutsal; A Cindas; M Ariyürek; N Renda; Z Koray; O Basgöze
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

9.  Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids.

Authors:  J Reeve; J Loftus; R Hesp; B M Ansell; D J Wright; P M Woo
Journal:  J Rheumatol       Date:  1993-07       Impact factor: 4.666

10.  Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis.

Authors:  P H Pepmueller; J T Cassidy; S H Allen; L S Hillman
Journal:  Arthritis Rheum       Date:  1996-05
View more
  7 in total

Review 1.  A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children.

Authors:  Karen E Hansen; Brian Kleker; Nasia Safdar; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2014-02-11       Impact factor: 5.532

2.  Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders.

Authors:  A M Huber; I Gaboury; D A Cabral; B Lang; A Ni; D Stephure; S Taback; P Dent; J Ellsworth; C LeBlanc; C Saint-Cyr; R Scuccimarri; J Hay; B Lentle; M Matzinger; N Shenouda; D Moher; F Rauch; K Siminoski; L M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

Review 3.  Glucocorticoid-induced osteoporosis in rheumatic diseases.

Authors:  Rosa Maria Rodrigues Pereira; Jozélio Freire de Carvalho; Ernesto Canalis
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

4.  Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone-mass determinants by using dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography.

Authors:  Stefano Stagi; Loredana Cavalli; Carla Signorini; Federico Bertini; Marco Matucci Cerinic; Maria Luisa Brandi; Fernanda Falcini
Journal:  Arthritis Res Ther       Date:  2014-03-31       Impact factor: 5.156

5.  Serum 25-hydroxyvitamin D and biochemical markers of bone metabolism in patients with juvenile idiopathic arthritis.

Authors:  R V Munekata; M T R A Terreri; O A B Peracchi; C Len; M Lazaretti-Castro; R O S Sarni; M O E Hilário
Journal:  Braz J Med Biol Res       Date:  2013-01-11       Impact factor: 2.590

Review 6.  Contemporary management of TMJ involvement in JIA patients and its orofacial consequences.

Authors:  Priit Niibo; Chris Pruunsild; Ülle Voog-Oras; Tiit Nikopensius; Triin Jagomägi; Mare Saag
Journal:  EPMA J       Date:  2016-06-02       Impact factor: 6.543

7.  Bone mineral density in children wth systemic lupus erythematosus and juvenile rheumatoid arthritis.

Authors:  Sara Kashef; Forugh Saki; Zohreh Karamizadeh; Mohammad Amin Kashef
Journal:  Ann Saudi Med       Date:  2007 Nov-Dec       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.